• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种皮肤科患者负担问卷的设计方法。

A Method for Designing a Patient Burden Questionnaire in Dermatology.

作者信息

Ezzedine Khaled, Bennani Mohammed, Shourick Jason, Taieb Charles

机构信息

University Hospital Henri-Mondor, Department of Dermatology, Créteil, France.

Qualees, Paris, France.

出版信息

Clin Cosmet Investig Dermatol. 2020 Aug 6;13:521-528. doi: 10.2147/CCID.S260323. eCollection 2020.

DOI:10.2147/CCID.S260323
PMID:32821144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7417926/
Abstract

INTRODUCTION

In recent years, the concept of "disease burden" has been given a central role in evaluating patient care, particularly in skin diseases. Measuring patient-reported outcomes (PRO) such as symptoms and disease burden may be useful.

AIM

To present a methodology that facilitates the development and validation of burden questionnaires for patients suffering from skin diseases.

METHODOLOGY

Based on past published burden questionnaires, a methodology for designing skin disease burden questionnaires was to be developed.

RESULTS

Based on 16 burden questionnaires developed and published over the last 10 years, the authors propose a standardized methodology for the easy design and validation of disease burden questionnaires for patients with chronic skin diseases. The authors provide detailed guidance for the conception, development and validation of the questionnaires, including reliability, internal consistency, external validity, cognitive debriefing, testing-retesting, translation and cross-cultural adaptation, as well as for statistical analysis.

CONCLUSION

The proposed methodology enhances the design and validation of disease burden questionnaires in dermatology. Burden questionnaires may be used in clinical research as well as in daily clinical practice.

摘要

引言

近年来,“疾病负担”的概念在评估患者护理方面,尤其是在皮肤病领域,发挥了核心作用。测量患者报告的结果(PRO),如症状和疾病负担,可能会有所帮助。

目的

介绍一种有助于为皮肤病患者开发和验证负担问卷的方法。

方法

基于过去发表的负担问卷,开发一种设计皮肤病负担问卷的方法。

结果

基于过去10年开发并发表的16份负担问卷,作者提出了一种标准化方法,以便轻松设计和验证慢性皮肤病患者的疾病负担问卷。作者为问卷的构思、开发和验证提供了详细指导,包括可靠性、内部一致性、外部有效性、认知反馈、重测、翻译和跨文化适应,以及统计分析。

结论

所提出的方法改进了皮肤病学中疾病负担问卷的设计和验证。负担问卷可用于临床研究以及日常临床实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b87/7417926/cda88a076989/CCID-13-521-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b87/7417926/cda88a076989/CCID-13-521-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b87/7417926/cda88a076989/CCID-13-521-g0001.jpg

相似文献

1
A Method for Designing a Patient Burden Questionnaire in Dermatology.一种皮肤科患者负担问卷的设计方法。
Clin Cosmet Investig Dermatol. 2020 Aug 6;13:521-528. doi: 10.2147/CCID.S260323. eCollection 2020.
2
Incontinentia pigmenti burden scale: designing a family burden questionnaire.失禁性色素营养不良负担量表:设计一种家庭负担问卷
Orphanet J Rare Dis. 2019 Nov 26;14(1):271. doi: 10.1186/s13023-019-1234-y.
3
Cross validation of the Turkish version of dermatology life quality index.土耳其版皮肤病生活质量指数的交叉验证
Int J Dermatol. 2006 Nov;45(11):1300-7. doi: 10.1111/j.1365-4632.2006.02881.x.
4
[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].[精神分裂症患者亲属的照顾者负担:测量工具概述]
Encephale. 2003 Mar-Apr;29(2):137-47.
5
[Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].[旨在评估医护人员对酒精依赖患者的知识、认知及实践情况的调查问卷的心理测量学特征]
Encephale. 2004 Sep-Oct;30(5):437-46. doi: 10.1016/s0013-7006(04)95458-9.
6
[Development and validation of a questionnaire to assess facial handicap in systemic sclerosis].[系统性硬化症面部残疾评估问卷的编制与验证]
Ann Dermatol Venereol. 2020 Oct;147(10):595-601. doi: 10.1016/j.annder.2020.04.023. Epub 2020 Jul 21.
7
[Cross-cultural adaptation and Spanish validation of Patient Satisfaction Questionnaire in dermatology (PSQ-18)].[皮肤病患者满意度问卷(PSQ - 18)的跨文化适应与西班牙语版验证]
J Healthc Qual Res. 2021 Sep-Oct;36(5):269-274. doi: 10.1016/j.jhqr.2021.04.004. Epub 2021 May 28.
8
Burden of albinism: development and validation of a burden assessment tool.白化病负担:负担评估工具的制定和验证。
Orphanet J Rare Dis. 2018 Sep 18;13(1):162. doi: 10.1186/s13023-018-0894-3.
9
[A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia].[一种用于评估精神分裂症患者照料者生活质量的新型法语工具的初步验证]
Encephale. 2011 Dec;37(6):425-32. doi: 10.1016/j.encep.2011.01.005. Epub 2011 Jul 8.
10
Translation, cross-cultural adaptation and validation of the Osteoarthritis Quality of Life (OAQoL) questionnaire for use in Portugal.翻译、跨文化调适及验证葡萄牙文版骨关节炎生命质量问卷(OAQoL)。
Rheumatol Int. 2019 Apr;39(4):715-722. doi: 10.1007/s00296-018-4197-8. Epub 2018 Nov 10.

引用本文的文献

1
What do families value most about the care home where their older adult relatives live?家庭最看重他们的老年亲属居住的养老院的哪些方面?
Front Public Health. 2024 Aug 8;12:1338649. doi: 10.3389/fpubh.2024.1338649. eCollection 2024.
2
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.患者报告的银屑病患者健康相关生活质量结局测量指标:系统评价。
JAMA Dermatol. 2024 May 1;160(5):550-563. doi: 10.1001/jamadermatol.2023.5439.
3
The Ectodermal Dysplasias-Burden of Disease Score: Development and Validation of an Ectodermal Dysplasia Family/Parental Burden Score.

本文引用的文献

1
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis.银屑病个体负担(I-BOP):一种针对银屑病患者的新评分工具的构建与验证
Clin Cosmet Investig Dermatol. 2020 May 4;13:325-332. doi: 10.2147/CCID.S249776. eCollection 2020.
2
Palmoplantar keratoderma: creating a disease burden questionnaire.掌跖角化病:创建疾病负担调查问卷。
J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e291-e293. doi: 10.1111/jdv.15563. Epub 2019 May 14.
3
Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs).
外胚层发育不全疾病负担评分:外胚层发育不全家庭/父母负担评分的制定与验证。
Acta Derm Venereol. 2023 Aug 30;103:adv5203. doi: 10.2340/actadv.v103.5203.
4
Development and evaluation of a psychosocial adaptation questionnaire for women with breast cancer treated with adjuvant endocrine therapy: a single-centre, cross-sectional study in China.中国一项单中心横断面研究:为接受辅助内分泌治疗的乳腺癌女性开发并评估一种社会心理适应问卷。
BMJ Open. 2022 Nov 21;12(11):e063082. doi: 10.1136/bmjopen-2022-063082.
白癜风患者影响量表(VIPs)短式的跨文化验证。
J Am Acad Dermatol. 2019 Nov;81(5):1107-1114. doi: 10.1016/j.jaad.2019.02.008. Epub 2019 Feb 11.
4
Building a scale for measuring burden of hand eczema: BoHEM.构建手部湿疹负担测量量表:BoHEM
J Am Acad Dermatol. 2019 Jun;80(6):1784-1785. doi: 10.1016/j.jaad.2018.12.036. Epub 2018 Dec 23.
5
Development and Validation of a New Tool to Assess Burden of Dietary Sodium Restriction in Patients with Chronic Heart Failure: The BIRD Questionnaire.开发和验证一种新工具来评估慢性心力衰竭患者饮食中钠限制的负担:BIRD 问卷。
Nutrients. 2018 Oct 7;10(10):1453. doi: 10.3390/nu10101453.
6
Burden of albinism: development and validation of a burden assessment tool.白化病负担:负担评估工具的制定和验证。
Orphanet J Rare Dis. 2018 Sep 18;13(1):162. doi: 10.1186/s13023-018-0894-3.
7
The impact of atopic dermatitis on sexual health.特应性皮炎对性健康的影响。
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):428-432. doi: 10.1111/jdv.15223. Epub 2018 Sep 23.
8
Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).一种评估敏感性皮肤负担(BoSS)的新工具的开发与验证。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2217-2223. doi: 10.1111/jdv.15186. Epub 2018 Aug 16.
9
Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey.中重度斑块状银屑病患者对皮肤清晰/几乎清晰的认知:全球银屑病认知调查结果
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2200-2207. doi: 10.1111/jdv.15065. Epub 2018 Jul 31.
10
Patient Burden is Associated with Alterations in Quality of Life in Adult Patients with Atopic Dermatitis: Results from the ECLA Study.特应性皮炎成年患者的疾病负担与生活质量改变相关:来自ECLA研究的结果
Acta Derm Venereol. 2018 Jul 11;98(7):713-714. doi: 10.2340/00015555-2940.